The Cooper Companies, Inc - Asset Resilience Ratio
The Cooper Companies, Inc (COO) has an Asset Resilience Ratio of 0.00% as of July 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read COO total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2023)
This chart shows how The Cooper Companies, Inc's Asset Resilience Ratio has changed over time. See COO net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down The Cooper Companies, Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see COO market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-200.00K | -0.0% |
| Total Liquid Assets | $-200.00K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: The Cooper Companies, Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
The Cooper Companies, Inc Industry Peers by Asset Resilience Ratio
Compare The Cooper Companies, Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026 |
Medical Instruments & Supplies | 2.86% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
Annual Asset Resilience Ratio for The Cooper Companies, Inc (2001–2023)
The table below shows the annual Asset Resilience Ratio data for The Cooper Companies, Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-10-31 | 0.00% | $100.00K | $11.66 Billion | -1.20pp |
| 2022-10-31 | 1.20% | $138.20 Million | $11.49 Billion | +0.20pp |
| 2021-10-31 | 1.00% | $95.90 Million | $9.61 Billion | -0.72pp |
| 2020-10-31 | 1.72% | $115.90 Million | $6.74 Billion | +0.30pp |
| 2019-10-31 | 1.42% | $89.00 Million | $6.27 Billion | +0.11pp |
| 2018-10-31 | 1.31% | $80.20 Million | $6.11 Billion | -0.52pp |
| 2017-10-31 | 1.83% | $88.80 Million | $4.86 Billion | -0.42pp |
| 2016-10-31 | 2.25% | $100.80 Million | $4.48 Billion | -- |
| 2015-10-31 | 0.00% | $0.00 | $4.46 Billion | -- |
| 2014-10-31 | 0.00% | $0.00 | $4.46 Billion | -- |
| 2013-10-31 | 0.00% | $0.00 | $3.14 Billion | -- |
| 2012-10-31 | 0.00% | $0.00 | $2.94 Billion | -- |
| 2011-10-31 | 0.00% | $0.00 | $2.62 Billion | -- |
| 2010-10-31 | 0.00% | $0.00 | $2.53 Billion | -- |
| 2004-10-31 | 0.23% | $1.83 Million | $811.56 Million | -0.59pp |
| 2003-10-31 | 0.81% | $5.75 Million | $705.56 Million | +0.33pp |
| 2002-10-31 | 0.48% | $2.75 Million | $571.12 Million | -1.53pp |
| 2001-10-31 | 2.01% | $7.98 Million | $396.85 Million | -- |
About The Cooper Companies, Inc
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and wome… Read more